Lindy Forte
Senior Vice President, Market Access and Pricing
Expertise:
Lindy has been working in the biotech, pharmaceutical and medical device industries for the past 24 years with a focus on strategic development of submission dossiers and finding novel solutions for access issues. Lindy’s background in prior pharmaceutical positions in clinical research and health economics provides a strong foundation for the strategic development of our HTA submissions work.
In addition to developing hundreds of reimbursement submission dossiers covering a wide array of therapeutic areas submitted to all payers (public, private, and hospital) across Canada, Lindy’s research has been published in peer-reviewed journals on topics related to the health and economic benefits of medications and/or drug reimbursement policy in Canada.
Articles by Lindy Forte
Navigating an Ever-evolving Canadian Market Access and Reimbursement Environment
These are just some of the trends currently shaping the Canadian market access environment. Achieving favourable market access and reimbursement outcomes for new treatments in this ever-changing landscape requires intimate knowledge of the Canadian landscape, processes and key stakeholders, careful strategic planning, sound tactics and skilled execution. Some key steps and considerations to maximize the chances of timely reimbursement are as follows: Up to 18 months pre-NOC: Information-gathering and early strategy work Conduct a market access landscape assessment Identify unmet needs and potential place in therapy Perform a strategic review of the clinical evidence to identify gaps that may pose a risk during HTA review, and potential mitigation strategies Evaluate […]